Last update:

Gastroenterology news

Liver transplant linked to significantly extended survival for alcohol-associated disease yet access is not equitable

People with alcohol-associated liver disease who received a liver transplant survived years longer than those who did not, but there are disparities in which patients receive a transplant. A large study published in Alcohol: ...

Cannabis use linked to higher death rates in people with alcohol-associated hepatitis

People with alcohol-associated hepatitis are more likely to die from the disease if they use cannabis. A large multinational study just published in Alcohol: Clinical and Experimental Research is the first to identify active ...

Common gut virus infects bacteria—not human cells

Thriving alongside trillions of bacteria in the human digestive tract is a vast population of viruses. Ever since one such denizen of the gut microbiome, known as picobirnavirus, was first spotted decades ago, researchers ...

Improve IBD bowel checks for early cancer detection

The first U.K.-wide analysis of bowel screening for patients with inflammatory bowel disease (IBD) has identified opportunities to improve the early detection of cancer. The study—the largest of its kind globally—found that ...

Sweeteners slow growth of important gut bacteria in lab tests

Cambridge researchers have shown how commonly used sweeteners slow the growth of certain gut bacteria. One sweetener in particular—isosteviol—when combined with the antidepressant duloxetine, significantly impaired two important ...

Roasted and browned: How gut bacteria break down heated foods

Crusty bread, fried meat and roasted coffee owe their characteristic taste and browning to chemical reactions that occur when foods are heated. In the so-called Maillard reaction, amino acids—the building blocks of proteins—react ...

Virtual tumor predicts response to liver cancer immunotherapy

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to predict which patients with a primary liver cancer called hepatocellular ...

KRAS-targeting drugs show promise for rare appendix cancer

Targeting mutant KRAS may offer a promising new treatment option for appendix cancer, according to research from The University of Texas MD Anderson Cancer Center published in the Journal of Hematology & Oncology.

Q&A: Rise in cyclosporiasis cases

Cyclosporiasis is a gastrointestinal illness caused by the microscopic parasite Cyclospora. People contract cyclosporiasis by consuming food or water contaminated with feces containing Cyclospora parasites. Health officials ...